←Back to Expert Scholars
Translational Medicine / 转化医学Rare Gynecologic Tumors
Jeff How
MD
🏢University of Texas MD Anderson Cancer Center🌐USA
Assistant Professor of Gynecologic Oncology
20
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Jeff How focuses on molecular profiling and treatment of rare gynecologic tumors including low grade serous ovarian carcinoma and mesonephric variants. He leads clinical trials evaluating MEK inhibitors and RAS pathway targeted agents. His research supports rational therapy selection in rare disease.
Share:
🧪Research Fields 研究领域
rare gynecologic tumors
low grade serous ovarian
molecular profiling
clinical trials
surgical oncology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Jeff How 的研究动态
Follow Jeff How's research updates
留下邮箱，当我们发布与 Jeff How（University of Texas MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment